The development of an effective preventive vaccine against the human immunodeficiency virus
(HIV) is an urgent national and international priority. However, a number of formidable
obstacles, encompassing biomedical, logistic, economic, social, and psychosocial concerns,
must be overcome to ensure the proper distribution and use of an HIV vaccine once it is
developed
Get full access to this article
View all access options for this article.
References
1.
Abramson, P.R.1988. Sexual assessment and the epidemiology of AIDS. Journal of Sex Research25:323-46.
2.
Abramson, P.R., and B. Rothschild.1988. Sex, drugs and matrices: Mathematical prediction of HIV infection. Journal of Sex Research25:106-22.
3.
AIDS and virginity. 1992. Nature359:2.
4.
American Academy of Pediatrics.1992. Report of the Infectious Disease Committee: Hepatitis B vaccine: Universal childhood immunization. Elk Grove, IL: American Academy of Pediatrics.
5.
Anderson, O.W.1965. Syphilis and society: Problems of control in the United States, 1912-1964. Research Series vol. 22. Chicago: Center for Health Administration Studies.
6.
Aral, S.O., and K.K. Holmes, 1991. Sexually transmitted diseases in the AIDS era. Scientific American264:62-69.
7.
Bailey, M.1992. Children and AIDS. In AIDS in the world , edited by J. Mann, D.J.M. Tarantola, and T. W. Netter, 667-77. Cambridge, MA: Harvard University Press.
8.
Baldwin, J.D., and J.I. Baldwin.1988. Factors affecting AIDS related sexual risk taking behavior among college students. Journal of Sex Research25:181-96.
9.
Barry, M.1988. Ethical considerations of human investigation in developing countries: The AIDS dilemma. New England Medical Journal319:1083-86.
10.
Baum, R.M., and R. Dagani.1990. AIDS vaccine, drug research advancing on several fronts. Chemical and Engineering News68:7-15.
11.
Becker, M.H.1974. The health belief model and personal health behavior. Health Education Monographs2:220-43.
12.
Benenson, A. S., ed. 1985. Control of communicable diseases in man. Washington, DC: American Public Health Association.
13.
Brandt, A.M.1985. No magic bullet: A social history of venereal disease in the United States. Oxford: Oxford University Press.
14.
—. 1988. AIDS in historical perspective: Four lessons from the history of sexually transmitted diseases. American Journal of Public Health78:367-71.
15.
Carovano, K.1991. More than mothers and whores: Redefining the AIDS prevention needs of women. International Journal of Health Services21:131-42.
16.
Carrier, J.M.1985. Mexican male bisexuality. In Bisexualties: Theory and research, edited by F. Klein and T. Wolf, 75-85. New York: Haworth.
17.
Catania, J.A., S.M. Kegeles, and T.J. Coates.1990. Towards an understanding of risk behavior: An AIDS risk reduction model (ARRM. Health Education Quarterly17:53-72.
18.
Cates, W., and A.R. Hinman.1992. AIDS and absolutism—The demand for perfection in protection. New England Journal of Medicine327:492-94.
19.
Centers for Disease Control. 1991. Vaccine information pamphlet: Polio. Atlanta: Centers for Disease Control.
20.
—. 1993. Update: Barrier protection against HIV infection and other sexually transmitted diseases. Morbidity and Mortality Weekly Report42:589-91.
21.
Christakis, N.A.1988. The ethical design of an AIDS vaccine trial in Africa . Hastings Center Report18:31-37.
22.
Cochran, S.D., and V.M. Mays.1990. Sex, lies, and HIVNew England Journal of Medicine322:774-75.
23.
Cohen, J.1993. AIDS research: The mood is uncertain. Science260:1254-61.
24.
Cutler, J.C., and R.C. Arnold.1988. Venereal disease control by health departments in the past: Lessons for the present. American Journal of Public Health78:372-76.
25.
Des Jarlais, D.C., and S.R. Friedman, 1987. Target groups for preventing AIDS among intravenous drug users. Journal of Applied Social Psychology17:251-68.
26.
Dixon, D.O., W.N. Rida, P.E. Fast, and D.F. Hoth.1993. HIV vaccine trials: Some design issues including sample size calculation. Journal ofAcquired Immune Deficiency Syndromes6:485-96.
27.
Emmons, C., J. Joseph, R. Kessler, C. Wortman, S. Montgomery, and D. Ostrow.1986. Psychosocial predictors of reported behavior change in homosexual men at risk for AIDS. Health Education Quarterly13:331-45.
28.
Enel, P., J. Charrel, M.-P. Larher, D. Reviron, C. Manuel, P. Auquier, and J.L. San Marco, 1992. HIV vaccination: The ethical issues. AIDS & Public Policy Journal7:50-55.
29.
Esparza, J., J. Homsy, R. Widdus, and J. Mann.1989. International testing of candidate vaccines for HIV: Scientific, ethical, social and legal issues. In Vaccines for sexually transmitted diseases, edited by A. Meheus, and R. E. Spier, 298-304. London : Butterworth's.
30.
Fishbein M., and S.E. Middlestadt .1989. Perceptions of personal susceptibility to harm. In Primary prevention of AIDS, edited by V.M. Mays, G.W. Albee, and S.W. Schneider, 93-110. Newbury Park, CA: Sage.
31.
Fisher, J.D., and W.A. Fisher.1992. Changing AIDS-risk behavior. Psychological Bulletin111:455-74.
32.
Fisher, J.D., and S.J. Misovich.1990. Evolution of college students' AIDS-related behavioral responses, attitudes, knowledge, and fear. AIDS Education and Prevention2:322-37.
33.
Francis, D.P., and J.C. Petricciani .1985. The prospects for and pathways toward a vaccine for AIDS. New England Journal of Medicine313:1586-90.
34.
Garrett, L.1992. The next epidemic. In AIDS in the world , edited by J. Mann, D.J.M. Tarantola, and T.W. Netter, 825-39. Cambridge, MA : Harvard University Press.
35.
Goldsmith, M.F.1987. Sex in the age of AIDS calls for common sense and "condom sense."Journal of the American Medical Association257:2261-66.
36.
Goudsmit, J., N.K. Back, and P.L. Nara.1991. Genomic diversity and antigenic variation of HIV-1: Links between pathogensis, epidemiology and vaccine development . FASEB Journal5:2427-36.
37.
Graham, B.S., and D.T. Karzon.1990. Development of an AIDS vaccine: Biological and ethical challenges. Infectious Disease Clinics of North American4:223-43.
38.
Haynes, B.F.1993. Scientific and social issues of human immunodeficiency virus vaccine development. Science260:1279-86.
39.
Hilleman, M.R.1992. Historical and contemporary perspectives in vaccine developments: From the vantage of cancer. Progress in Medical Virology39:1-18.
40.
Joseph, J.G., S.B. Montgomery, C.-A. Emmons, R.C. Kessler, D.G. Ostrow, C.B. Wortman, K. O'Brien, M. Eller, and S. Eshelman.1987. Magnitude and determinants of behavioral risk reduction: Longitudinal analysis of a cohort at risk for AIDS. Psychology and Health1:73-96.
41.
Karzon, D.T., D.P. Bolognesi, and W.C. Koff.1992. Development of a vaccine for the protection of AIDS: A critical appraisal. Vaccine10:1039-52.
42.
Kelly, J.A., J.S. St. Lawrence, S. Smith, Jr., H.V. Hood, and D.J. Cook.1987. Medical students' attitudes toward AIDS and homosexual patients. Journal of Medical Education62:549-56.
43.
Klepinger, D.H., J.O.G. Billy, K. Tanfer, and W.R. Grady.1993. Perceptions of AIDS risk and severity and their association with risk-related behavior among U.S. men. Family Planning Perspectives25:74-82.
44.
Koff, W.C.1990. The prospects for AIDS vaccines. In AIDS: Problems and prospects, edited by L. Corey , 85-96. New York: Norton.
45.
Koff, W.C., and D.F. Hoth.1988. Development and testing of AIDS vaccines . Science241:426-32.
46.
Koff, W.C., and M.J. Glass.1992. Future direction in HIV vaccine development . AIDS Research and Human Retroviruses8:1313-15.
47.
Koop, C.E.1987. Surgeon General's report on acquired immune deficiency syndrome. Washington, DC: U.S. Department of Health and Human Services.
48.
Lewis, C.E., and K. Montgomery.1992. Primary care physicians' refusal to care for patients infected with the human immunodeficiency virus. Western Journal of Medicine156:36-38.
49.
Magaña, J.R., and J.M. Carrier.1991. Mexican and Mexican American male sexual behavior and spread of AIDS in California. Journal of Sex Research28:425-41.
50.
Mann, J., D.J.M. Tarantola, and T.W. Netter.1992. The HIV pandemic: Status and trends . In AIDS in the world, edited by J. Mann, D.J.M. Tarantola, and T. W. Netter, 11-108. Cambridge, MA: Harvard University Press.
51.
Mariner, W.K.1988. Why clinical trials of AIDS vaccines are premature. American Journal of Public Health79:86-91.
52.
Martin, J.L., M.A. Garcia, and S.T. Beatrice.1989. Sexual behavior changes and HIV antibody in a cohort of New York City gay men. American Journal of Public Health79:501-503.
53.
Matthews, T.J., and D.P. Bolognesi.1988. AIDS vaccines. Scientific American261:120-27.
54.
May R.M., and R.M. Anderson.1987. Transmission dynamics of HIV infection . Nature326: 137-42.
55.
Mays, V.M., and S.D. Cochran.1990. Methodological issues in the assessment and prediction of AIDS risk-related sexual behaviors among black Americans . In AIDS and sex: An integrated and biobehavioral approach , edited by B. Voeller, J. M. Reinisch, and M. Gottleib , 97-120. New York: Oxford University Press.
56.
Merson, M.H.1993. Slowing the spread of HIV: Agenda for the 1990s. Science260:1266-68.
57.
Oehen, S., H. Hengartner, and R.M. Zinkernagel .1991. Vaccination for disease. Science251:195-98.
58.
Pape, J.W., M.M. Deschamps, R.I. Verdier, S. Jean, M. Desvarieux, G. Taverne, C. Gelin, P.R. Hyppolite, J. Denize, R. Mellon, B. Liautaud, and W.D. Johnson, Jr.1992. The urge for an AIDS vaccine: Perspectives from a developing country. AIDS Research and Human Retroviruses8:1535-37.
59.
Pinkerton, S.D., and P.R. Abramson.1992a. Base rates revisited: Assessment strategies for HIV/AIDS. Journal of Sex Research29:407-24.
60.
—. 1992b. Is risky sex rational? Journal of Sex Research29:561-68.
61.
—. 1993. Evaluating the risks: A Bernoulli process model of HIV infection and risk reduction. Evaluation Review17:504-28.
62.
—. Forthcoming-a. An alternative model of the reproductive rate of HIV infection: Formulation, evaluation, and implications for risk reduction interventions . Evaluation Review.
63.
—. Forthcoming-b. A magic bullet against AIDS? (Letter). Science.
64.
Potts, M., and R. V Short.1989. Condoms for the prevention of HIV transmission: Cultural dimensions. AIDS3 (S1):S259-S263.
65.
Reiss, I.L., and R.K. Leik, 1989. Evaluating strategies to avoid AIDS: Number of partners vs. use of condomsJournal of Sex Research26:411-33.
66.
Rosenstock, I.M.1974The health belief model and preventive health behavior . Health Education Monographs2:354-86.
67.
Schechter, M.T., K.J.P. Craib, B. Willoughby, B. Douglas, W.A. McLeod, M. Maynard, P. Constance, and M. O' Shaughnessy .1988. Patterns of sexual behavior and condom use in a cohort of homosexual men. American Journal of Public Health78:1535-38.
68.
Stall, R., S. Heurtin-Roberts, L. McKusick, C. Hoff, and S.W. Lang.1990. Sexual risk for HIV transmission among singles-bar patrons in San Francisco. Medical Anthropology Quarterly4:115-28.
69.
Veljkovic, V., and R. Metlas.1993. Potentially negative effects of AIDS vaccines based on recombinant viruses carrying HIV-1 derived envelope gene . Vaccine11:291-92.
70.
Weinstein, N.D.1982. Unrealistic optimism about susceptibility to health problems . Journal of Behavioral Medicine10:481-500.
71.
—. 1989. Perceptions of personal susceptibility to harm. In Primary prevention of AIDS, edited by V. M. Mays, G. W. Albee, and S. W. Schneider, 142-67. Newbury Park, CA: Sage.
